Good evening :)
Place Order
Add to Watchlist
Home
Portfolio
Search
GoldGold
More

Panjon Ltd

PANJON

Panjon Ltd

PANJON
Health CarePharmaceuticals
SmallcapWith a market cap of ₹37 cr, stock is ranked 3,712
High RiskStock is 3.20x as volatile as Nifty
21.581.31% (+0.28)
21.581.31% (+0.28)

Price Chart

High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹37 cr, stock is ranked 3,712
High RiskStock is 3.20x as volatile as Nifty

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹37 cr, stock is ranked 3,712
High RiskStock is 3.20x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
194.952.49—
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
50.266.380.53%

Forecast & Ratings

Detailed Forecast 
—
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Panjon Limited is engaged in the manufacturing and trading of consumer and pharmaceutical products. The Company is also engaged in manufacturing allopathic and ayurvedic formulations. The Company's segments include manufacturing and trading.

Peers

Compare with peers 
Compare with Peers

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Price Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Revenue Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Earnings Per Share Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Lower than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of -13.14%, vs industry avg of 9.03%

Decreasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share decreased from 0.01% to 0%

Lower than Industry Net Income

Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 2.71%, vs industry avg of 15.28%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue12.6914.5020.3126.3026.7214.878.736.4713.0016.00
Raw Materialssubtract11.0912.7318.7923.3523.6011.684.541.989.1715.44
Power & Fuel Costsubtract0.140.130.140.150.160.100.080.070.07
Employee Costsubtract0.230.360.340.340.470.420.460.470.60
Selling & Administrative Expensessubtract1.180.860.731.821.521.503.053.152.69
Operating & Other expensessubtract-0.30-0.08-0.32-0.040.360.654.340.430.03
Depreciation/Amortizationsubtract0.140.130.110.150.270.230.200.210.220.28
Interest & Other Itemssubtract0.170.190.280.240.150.100.070.050.060.09
Taxes & Other Itemssubtract-0.340.060.120.150.220.090.14-0.690.00—
EPS0.250.080.080.09-0.020.06-2.680.520.100.12
DPS0.000.000.000.000.000.000.000.000.000.00
Payout ratio0.000.000.000.000.000.000.000.000.000.00
See Costs

EPS and DPS in ₹. Other numbers except Payout Ratio in ₹ cr

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2020

Annual report

PDF
FY 2021

Annual report

PDF
FY 2022

Annual report

PDF
FY 2023

Annual report

PDF
FY 2024

Annual report

PDF
 

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Valuation

Technical

Forecast

ScreenerCompare valuation on Screener

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Panjon Ltd231.512.49—
Sun Pharmaceutical Industries Ltd44.986.420.75%
Cipla Ltd29.134.480.87%
Torrent Pharmaceuticals Ltd64.7115.630.88%

Price Comparison

Compare PANJON with any stock or ETF
Compare PANJON with any stock or ETF
PANJON
Loading...

Shareholdings

Promoter Holdings Trend

Increased Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has increased by 4.66%

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding56.69%0.00%0.00%0.00%43.31%

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Shareholding History

JunSepDec '23MarJunSep0.00%0.00%0.00%0.00%0.00%0.00%

Insider Trades & Bulk Deals

Loading...

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No Dividends

Dividends are the portion of earnings that a company distributes to all its shareholders every year

PANJON has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

Dividends

Hmm, looks like data is unavailable here. Please come back after some time
News & Opinions
Earnings
Panjon standalone net profit rises 75.00% in the September 2024 quarter

Net profit of Panjon rose 75.00% to Rs 0.07 crore in the quarter ended September 2024 as against Rs 0.04 crore during the previous quarter ended September 2023. Sales rose 160.00% to Rs 3.38 crore in the quarter ended September 2024 as against Rs 1.30 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales3.381.30 160 OPM %2.072.31 - PBDT0.120.06 100 PBT0.070.04 75 NP0.070.04 75 Powered by Capital Market - Live

1 week agoCapital Market - Live
Corporate
Panjon to table results

Panjon will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live

1 week agoCapital Market - Live
Earnings
Panjon standalone net profit rises 50.00% in the June 2024 quarter

Net profit of Panjon rose 50.00% to Rs 0.03 crore in the quarter ended June 2024 as against Rs 0.02 crore during the previous quarter ended June 2023. Sales rose 68.55% to Rs 2.09 crore in the quarter ended June 2024 as against Rs 1.24 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales2.091.24 69 OPM %0.48-3.23 - PBDT0.080.04 100 PBT0.030.02 50 NP0.030.02 50 Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
Panjon to declare Quarterly Result

Panjon will hold a meeting of the Board of Directors of the Company on 13 August 2024.Powered by Capital Market - Live

3 months agoCapital Market - Live

Panjon Standalone March 2023 Net Sales at Rs 1.30 crore, down 17.42% Y-o-Y

1 year agoMoneycontrol

Panjon Standalone December 2022 Net Sales at Rs 1.37 crore, down 58.77% Y-o-Y

1 year agoMoneycontrol

Panjon standalone net profit declines 40.00% in the December 2022 quarter

1 year agoBusiness Standard

Panjon Standalone September 2022 Net Sales at Rs 1.93 crore, up 18.33% Y-o-Y

1 year agoMoneycontrol

Panjon Standalone September 2022 Net Sales at Rs 1.93 crore, up 18.33% Y-o-Y

2 years agoMoneycontrol

Panjon Standalone March 2022 Net Sales at Rs 1.58 crore, up 1.28% Y-o-Y

2 years agoMoneycontrol